DOI QR코드

DOI QR Code

The ProtectiveEffect of Oryeongsan, Geumgwe-sinkihwan, and Jwagwieum on Renal Injury in Rats with Unilateral Ureteral Obstruction

편측성 요관폐색으로 유발된 신장 질환 백서 모델에서 오령산, 금궤신기환, 좌귀음의 보호효과

  • Byung Hyuk Han (Hanbang Cardio-Renal Syndrome Research Center, Wonkwnag University) ;
  • Je Kuk Yu (Professional Graduate School of Korean Medicine, Wonkwang University) ;
  • Youn Jae Jang (Hanbang Cardio-Renal Syndrome Research Center, Wonkwnag University) ;
  • Hye Yoom Kim (Hanbang Cardio-Renal Syndrome Research Center, Wonkwnag University) ;
  • Jung Joo Yoon (Hanbang Cardio-Renal Syndrome Research Center, Wonkwnag University) ;
  • Nam Geun Cho (Professional Graduate School of Korean Medicine, Wonkwang University) ;
  • Ho Sub Lee (Hanbang Cardio-Renal Syndrome Research Center, Wonkwnag University) ;
  • Dae Gill Kang (Hanbang Cardio-Renal Syndrome Research Center, Wonkwnag University)
  • 한병혁 (원광대학교 한방심신증후군연구센터) ;
  • 유제국 (원광대학교 한의학전문대학원) ;
  • 장윤재 (원광대학교 한방심신증후군연구센터) ;
  • 김혜윰 (원광대학교 한방심신증후군연구센터) ;
  • 윤정주 (원광대학교 한방심신증후군연구센터) ;
  • 조남근 (원광대학교 한의학전문대학원) ;
  • 이호섭 (원광대학교 한방심신증후군연구센터) ;
  • 강대길 (원광대학교 한방심신증후군연구센터)
  • Received : 2023.07.20
  • Accepted : 2023.08.11
  • Published : 2023.08.31

Abstract

Ureteral obstruction can be causes of renal dysfunction and renal injury at late period of kidney pathology. The purpose of this study was to determine the protective effects of Oryeongsan (ORS), Geumgwe-sinkihwan (GSH), and Jwagwieum (JGE) in rats with unilateral ureteral obstruction (UUO). The animal models were divided into five groups randomly at the age of 5 weeks; Control group: SD male rats (n=10), UUO group: SD male rats with UUO surgery (n=10), ORS group: SD male rats with UUO surgery + ORS 200 mg/kg/day (n=10), GSH group: SD male rats with UUO surgery + GSH 200 mg/kg/day (n=10), JGE group: SD male rats with UUO surgery + JGE 200 mg/kg/day (n=10). Treatment with ORS, GSH, and JGE significantly ameliorate creatinine clearance(Ccr). The present results also showed that ORS, GSH, and JGE improved the morphological aspects of renal tissues. These prescriptions also reduced the expression levels of cytokines such as TNF-α, IL-1β, and IL-6. In Kidney, UUO increased the expression levels of inflamasome markers such as NLRP3, ASC, and Caspase-1. However, ORS, GSH, and JGE suppressed these levele. Treatment with these prescriptions reduced kidney inflammation markers such as Neutrophil Gelatinase Associated Lipocalin (NGAL) and kidney injury molecule -1 (KIM-1). Therefore, these findings suggest that ORS, GSH, and JGE has a protective effect on renal injury by alleviating renal inflammation and improving renal function in rats with UUO.

Keywords

Acknowledgement

본 논문의 연구는 원광대학교 (2022)의 지원을 받아 수행되었으며 이에 감사드립니다.

References

  1. Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's principles of internal medicine (19th ed.). New York: Mc Graw Hill Education. 2015.
  2. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1992;20:1-17. https://doi.org/10.1016/S0272-6386(12)80312-X
  3. Ophascharoensuk V, Giachelli CM, Gordon K, et al. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int. 1999;56:571-580. https://doi.org/10.1046/j.1523-1755.1999.00580.x
  4. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009;75:1145-1152. https://doi.org/10.1038/ki.2009.86
  5. Better OS, Arieff AI, Massry SG, Kleeman CR, Maxwell MH. Studies on renal function after relief of complete unilateral ureteral obstruction of three months' duration in man. Am J Med. 1973;54:234-240. https://doi.org/10.1016/0002-9343(73)90228-3
  6. Ucero AC, Benito-Martin A, Izquierdo MC, et al. Unilateral ureteral obstruction: beyond obstruction. Int Urol Nephrol. 2014;46:765-776. https://doi.org/10.1007/s11255-013-0520-1
  7. Hocherl K, Schmidt C, Kurt B, Bucher M. Inhibition of NF-kappaB ameliorates sepsis-induced downregulation of aquaporin-2/V2 receptor expression and acute renal failure in vivo. Am J Physiol Renal Physiol. 2010;298:F196-F204. https://doi.org/10.1152/ajprenal.90607.2008
  8. Branten AJ, Vervoort G, Wetzels JF. Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant. 2005;20:707-711. https://doi.org/10.1093/ndt/gfh719
  9. Carrie BJ, Golbetz HV, Michaels AS, Myers BD. Creatinine: an inadequate filtration marker in glomerular diseases. Am J Med. 1980;69:177-182. https://doi.org/10.1016/0002-9343(80)90376-9
  10. Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis. 1993;251-259.
  11. Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis. 1993;251-259.
  12. Yang X, Wu Y, Li Q, et al. CD36 Promotes Podocyte Apoptosis by Activating the Pyrin Domain-Containing-3 (NLRP3) Inflammasome in Primary Nephrotic Syndrome. Med Sci Monit. 2018;24:6832-6839. https://doi.org/10.12659/MSM.909810
  13. Sutterwala FS, Ogura Y, Flavell RA. The inflammasome in pathogen recognition and inflammation. J Leukoc Biol. 2007;82:259-264. https://doi.org/10.1189/jlb.1206755
  14. Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140:821-832. https://doi.org/10.1016/j.cell.2010.01.040
  15. Yan J, Li Y, Yang H, et al. Interleukin-17A participates in podocyte injury by inducing IL-1 β secretion through ROS-NLRP3 inflammasome-caspase-1 pathway. Scand J Immunol. 2018;87:e12645. https://doi.org/10.1111/sji.12645
  16. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237-244. https://doi.org/10.1046/j.1523-1755.2002.00433.x
  17. Devarajan P. Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury. Nephrol Dial Transplant. 2008:3737-3743.
  18. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005;115(3):610-621. https://doi.org/10.1172/JCI200523056
  19. Merika L, Rasic S, Serdarevic N. Importance of determination of urine neutrophile gelatinase associated lipocalin in early detection of acute kidney injury. Coll Antropol. 2014;38(1):161-166.
  20. Kidher E, Harling L, Ashrafian H, Naase H, Chukwuemeka A, Anderson J. Pulse wave velocity and neutrophil gelatinase-associated lipocalin as predictors of acute kidney injury following aortic valve replacement. J Cardiothorac Surg. 2014;9:89.
  21. Liu W, Tang F, Deng Y, Li X, Lan T, Zhang X. Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition. Mol Cell Biochem. 2009;325:99.
  22. He L, Rong X, Jiang J, M Liu, P Q, Li L. Amelioration of anti-cancer agent adriamycininduced nephritic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine. Food Chem Toxicol. 2008;46:1452.
  23. Han BH, Lee HK, Jang SH, Tai AL, Jang YJ, Yoon JJ, Kim HY, Lee HS, Lee YJ, Kang DG. Effect of Geumgwe-sinkihwan on Renal Dysfunction in Ischemia/Reperfusion-Induced Acute Renal Failure Mouse. Nutrients. 2021;13(11):3859.
  24. Na SW, Jang YJ, Hong MH, Yoon JJ, Lee HS, Kim HY, Kang DG. Protective Effect of Joa-Gui Em through the Improvement of the NLRP3 and TLR4/NF-κb Signaling by Ischemia/Reperfusion-Induced Acute Renal Failure Rats. eCAM. 2021;7178868.
  25. Zhong TY, Tang J, Liu YW, Li ZJ, Chen DY, Zhao MZ, et al. High mobility group box-1 stimulates proinflammatory cytokine production in endothelial cells via MAP kinases. Europe PMC. 2009;29(8):1517-1520.
  26. Zhao YY, Cheng XL, Cui JH, Yan XR, Wei F, Bai X, Lin RC. Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: A serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm. Clinica Chimica Acta. 2012;413(19-20):1438-1445. https://doi.org/10.1016/j.cca.2012.06.005
  27. Yu HY. Progression of chronic renal failure. Arch Intern Med. 2003;163:1417-1429. https://doi.org/10.1001/archinte.163.12.1417
  28. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med. 2004;43:9-17. https://doi.org/10.2169/internalmedicine.43.9
  29. Shobeiri N, Adams MA, Holden RM. Vascular calcification in animal models of CKD. A review Am J Nephrol. 2010;31:471-481. https://doi.org/10.1159/000299794
  30. Spector DA, Yang Q, Wade JB. High urea and creatinine concentrations and urea transporter B in mammalian urinary tract tissues. Am J Physiol Renal Physiol. 2007;292(1):467-474. https://doi.org/10.1152/ajprenal.00181.2006
  31. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factOS, and relationship to mortality. Am J Med. 1997;103(5):368-375. https://doi.org/10.1016/S0002-9343(97)00150-2
  32. Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol. 2007;27:195-207. https://doi.org/10.1016/j.semnephrol.2007.01.012
  33. Xiang H, Zhu F, Xu ZF, Xoing J. Role of inflammasomes in kidney diseases via both canonical and non-canonical pathways. Front Cell Dev Bioll. 2020;8:106.
  34. Das M, Das DK. Molecular mechanism of preconditioning. IUBMB Life. 2008;60:199-203. https://doi.org/10.1002/iub.31
  35. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273(7):4135-4142. https://doi.org/10.1074/jbc.273.7.4135
  36. Devarajan P, Mishra J, Supavekin S, Patterson LT, Steven PS. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab. 2003;80(4):365-376. https://doi.org/10.1016/j.ymgme.2003.09.012